ArticlePloS one2012

An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.

Manisha Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.